Skip to main content
drug_type
RELEVANT_DRUG
intervention_type
Biological
drug_description
Human IgG1 broadly neutralizing monoclonal antibody against HIV-1 Env with LS Fc mutations to increase FcRn binding and extend half-life. It targets the gp120 V3-glycan supersite to neutralize diverse HIV-1 strains, block gp120 engagement with CD4/co-receptors to prevent viral entry, and via Fc effector functions (ADCC/ADCP) may promote clearance of Env-expressing infected cells.
nci_thesaurus_definition
NCI thesaurus definition not available.
drug_mesh_term
Antibodies, Neutralizing
drug_category
INHIBITORY ANTIBODY
drug_class
Inhibitor
drug_delivery_route
Intravenous
drug_mechanism_of_action
10-1074-LS is a human IgG1 broadly neutralizing monoclonal antibody that binds the HIV-1 Env gp120 V3-glycan supersite, neutralizing diverse virions and blocking gp120 engagement with CD4 and co-receptors to prevent viral entry. LS Fc mutations enhance FcRn binding and extend serum half-life. Through Fc effector functions (e.g., ADCC/ADCP), it may also promote clearance of Env-expressing infected cells.
drug_name
10-1074-LS
nct_id_drug_ref
NCT05079451